Intracoronary application of abciximab in patients with ST-Elevation myocardial infarction

被引:0
|
作者
Woehrle, Jochen [1 ]
Mayer, Christine [1 ]
Kochs, Matthias [1 ]
Hombach, Vinzenz [1 ]
Nusser, Thorsten [1 ]
机构
[1] Univ Ulm, D-89069 Ulm, Germany
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2007年 / 100卷 / 8A期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:169L / 169L
页数:1
相关论文
共 50 条
  • [1] Intracoronary administration of abciximab in ST-elevation myocardial infarction
    Gibson, C. Michael
    Zorkun, Cafer
    Kunadian, Vijayalakshmi
    [J]. CIRCULATION, 2008, 118 (01) : 6 - 8
  • [2] Intracoronary application of abciximab in ST-elevation myocardial infarction improves left ventricular function at 6 months
    Fuernau, G.
    Friedenberger, J.
    Dumjahn, A.
    Eitel, I.
    Desch, S.
    Schuler, G.
    Thiele, H.
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 : 897 - 897
  • [3] Intracoronary Application of Abciximab in ST-Elevation Myocardial Infarction Improves Left Ventricular Function at 6 Months
    Fuernau, Georg
    Eitel, Ingo
    Friedenberger, Josef
    Dumjahn, Annett
    Desch, Steffen
    Schuler, Gerhard
    Thiele, Holger
    [J]. CIRCULATION, 2010, 122 (21)
  • [4] Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary coronary intervention
    Thiele, Holger
    Schindler, Kathrin
    Friedenberger, Josef
    Eitel, Ingo
    Fuernau, Georg
    Grebe, Eigk
    Kivelitz, Dietmar
    Schuler, Gerhard
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A211 - A211
  • [5] Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary coronary intervention
    Thiele, H.
    Thiele, H.
    Schindler, K.
    Friedenberger, J.
    Eitel, I.
    Fuernau, G.
    Peschel, T.
    Grebe, E.
    Kivelitz, D.
    [J]. EUROPEAN HEART JOURNAL, 2007, 28 : 669 - 670
  • [6] Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention - The randomized leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial
    Thiele, Holger
    Schindler, Kathrin
    Friedenberger, Josef
    Eitel, Ingo
    Fuernau, Georg
    Grebe, Eigk
    Erbs, Sandra
    Linke, Axel
    Moebius-Winkler, Sven
    Kivelitz, Dietmar
    Schuler, Gerhard
    [J]. CIRCULATION, 2008, 118 (01) : 49 - 57
  • [7] Optimizing the use of abciximab and intracoronary stents in patients with acute ST elevation myocardial infarction
    Velianou J.L.
    Al Suwaidi J.
    Mathew V.
    [J]. American Journal of Cardiovascular Drugs, 2002, 2 (5) : 315 - 322
  • [8] Aborted myocardial infarction in intracoronary compared with standard intravenous abciximab administration in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction
    Eitel, Ingo
    Desch, Steffen
    Schindler, Kathrin
    Fuernau, Georg
    Schuler, Gerhard
    Thiele, Holger
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 153 (01) : 21 - 25
  • [9] Polyhedrocytes in intracoronary thrombi frompatients with ST-elevation myocardial infarction
    Zabczyk, Michal
    Sadowski, Marcin
    Zalewski, Jaroslaw
    Undas, Anetta
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 179 : 186 - 187
  • [10] Administration of intracoronary Eptifibatide during ST-elevation myocardial infarction
    Pinto, DS
    Kirtane, AJ
    Ruocco, NA
    Deibele, AJ
    Shui, A
    Buros, J
    Murphy, SA
    Gibson, CM
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (11): : 1494 - 1497